CALIMESA, Calif., March 24, 2006 (PRIMEZONE) -- Ingen Technologies, Inc. (Pink Sheets:IGTG), a medical device manufacturer of OxyAlert(tm), OxyView, and Secure Balance(tm), announced today that Alexander Haig, former Secretary of State for President Ronald Reagan, will interview and feature Ingen Technologies through the television production "Health Journal Television" to be released in May 2006.
Increasing problems of malpractice lawsuits, medical waste efficiency, and growth in the elderly population have increased a demand for breakthrough medical products. Ingen Technologies shows us how they are meeting these special needs with innovative product developments.
Health Journal Television has elected to include a 3-4 minute segment that includes interviews from key executives, product presentation, and give an overview by field experts as a part of a 30 minute show that illustrates how the Company is impacting the industry. The domestic television exposure includes 84 million television households through CNBC (as paid programming) with 58 million on DirectTV and Dish Network. In addition, the Bravo Network (as paid programming) includes 70 Million cable households. The segment will be televised on the Health & Science Television Network and the Long Term Care Network; both networks deliver educational medical programming via satellite to 650 acute care facilities and 750 long-term care facilities, respectively.
The commercial airline industry, inclusive of United, Delta, Jet Blue, and Frontier airlines reach travelers via satellite television on CNBC (as paid programming). Program Producer Mr. J.L. Haber added, "Ingen Technologies is at the forefront of their industry. Their innovative solutions have made them a natural to appear on the show."
International television exposure includes Hong Kong's (prime time) leading television networks to 1.9 million potential television households, and Canada's 2 million potential television households through DirectTV and Dish network. Between Hong Kong, Canada, and International Flight by United Airlines, the program targets an affluent, educated audience worldwide, including business executives, managers and decision-makers worldwide.
Health Journal Television is incorporated into the curriculum of nine Medical Universities/Libraries in the United States. The show, as well as the Company products, are capable of being integrated into the minds of future medical professionals at Baylor College of Medicine, Marquette General Health System, The National Library of Medicine, Dartmouth Medical School, New York University School of Medicine, University of Florida Health Science Center Libraries and more!
There are an additional 75 million Internet and New Media users that include Video On-Demand and the HealthJournalTV.com website.
Scott Sand, Chairman & CEO commented: "We were contacted by Multi-Media productions (USA) with a very strong interest and enthusiasm to be a part of Alexander Haig's Health Journal Television. It is an honor and a privilege to be invited to participate with such a credible program. Our products and services are gaining momentum and recognition within our healthcare system. We believe that OxyView and Secure Balance (tm) will benefit greatly to both the consumers and our company and its many shareholders."
About Ingen Technologies, Inc.
Ingen Technologies, Inc. is a public company trading under (Pink Sheets:IGTG), which has been in business since 1999. IGTG is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products. Ingen Technologies, Inc. ("Ingen" or the "Company"), a Georgia Corporation, was formed as a result of a reverse merger in March 2004 whereby Ingen became a publicly-owned company and commenced trading in the Over-The-Counter market on the Pink Sheets. Ingen (GA) is a holding company which owns or has intellectual property rights to certain proprietary devices which primarily provide diagnostic and safety features to health practitioners and patients. Operations are conducted through a 100%-owned subsidiary, Ingen Technologies, Inc. of Nevada, which has been in business since 1999 when Chairman/CEO Scott R. Sand founded it. The principal executive office is in Yucaipa, CA, northeast of Los Angeles.
The Company's flagship product is OxyAlert(tm), a second-generation design of the Company's BAFI(tm) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(tm) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.
The newest product, OxyView, has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow for patients in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities. This product enhances the safety, assurance and accuracy of patients being administered oxygen from any source. OxyView is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the patient.
The Secure Balance(tm) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT(r), Inc. in San Diego, California. The Secure Balance(tm) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.
The Pure Produce product is a continuing research and development program currently under design. This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.
"Our team of professionals has developed our medical products for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.
For more information, visit www.ingen-tech.com
Investor Relations Contact: Scott R. Sand, C.E.O & Chairman Ingen Technologies, Inc. - Administrative Office 35193 Avenue "A", Suite-C Yucaipa, California 92399 Phone: (800) 259-9622 or (909) 790-7180 Fax: (800) 777-1186 or (909) 795-6340 Email: Info@ingen-tech.com
A Member of the Better Business Bureau
A Member of the Chamber of Commerce
A Licensed Business in the City of Yucaipa
The Ingen Technologies, Inc. logo is available at: http://www.primezone.com/newsroom/prs/?pkgid=2472
Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements that are made pursuant to "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.